Sign up to save your podcasts
Or
Share FDA recommends guidance Revision Over Dialysis System Tubing Concern
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA recommends guidance Revision Over Dialysis System Tubing Concern
The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.
View all episodes
By TheBrief.HealthThe Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.